Cognitive dysfunction: a growing link between diabetes and Alzheimer’s disease

Diagnosis and Classification of Diabetes Mellitus

American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 14,019 · see citing works

IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045

Cho, N. H., Shaw, J. E., Karuranga, S., Huang, Y., da Rocha Fernandes, J. D., Ohlrogge, A. W., & Malanda, B. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.02.023 · Cited by 7,283 · see citing works

MicroRNA therapeutics: towards a new era for the management of cancer and other diseases

Rupaimoole, R., & Slack, F. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.246 · Cited by 4,741 · cited 1× · see citing works

Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables

Ahlqvist, E., Storm, P., Käräjämäki, A., Martinell, M., Dorkhan, M., Carlsson, A., Vikman, P., Prasad, R. B., Aly, D. M., Almgren, P., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30051-2 · Cited by 2,335 · see citing works

Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury

Goldin, A., Beckman, J. A., Schmidt, A. M., & Creager, M. A. (2006) · Circulation · doi:10.1161/circulationaha.106.621854 · Cited by 2,261 · see citing works

RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease

Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012 · see citing works

Diagnosis and classification of diabetes mellitus

American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s062 · Cited by 1,817 · see citing works

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?

Steen, E., Terry, B. M., J. Rivera, E., Cannon, J. L., Neely, T. R., Tavares, R., Xu, X. J., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7107 · Cited by 1,703 · see citing works

Alzheimer’s disease is type 3 diabetes—Evidence reviewed

de la Monte, S. M., & Wands, J. R. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200619 · Cited by 1,158 · see citing works

Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group

Karvonen, M., Viik-Kajander, M., Moltchanova, E., Libman, I., LaPorte, R., & Tuomilehto, J. (2000) · Diabetes Care · doi:10.2337/diacare.23.10.1516 · Cited by 1,072 · see citing works

WHO Global report on diabetes: A summary

Roglić, G. (2016) · International Journal of Noncommunicable Diseases · doi:10.4103/2468-8827.184853 · Cited by 1,025 · see citing works

New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain

Feldman, E. L., Nave, K.-A., Jensen, T. S., & Bennett, D. L. H. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.005 · Cited by 915 · see citing works

Insulin-degrading Enzyme Regulates Extracellular Levels of Amyloid β-Protein by Degradation

Qiu, W. Q., Walsh, D. M., Ye, Z., Vekrellis, K., Zhang, J., Podlisny, M. B., Rosner, M. R., Safavi, A., Hersh, L. B., & Selkoe, D. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32730 · Cited by 812 · see citing works

Type 2 diabetes as a risk factor for dementia in women compared with men: a pooled analysis of 2·3 million people comprising more than 100,000 cases of dementia

Chatterjee, S., Peters, S. A. E., Woodward, M., Mejia Arango, S., Batty, G. D., Beckett, N., Beiser, A., Borenstein, A. R., Crane, P. K., Haan, M., et al. (2016) · Diabetes Care · doi:10.2337/dc15-1588 · Cited by 711 · see citing works

Hyperinsulinemia and risk of Alzheimer disease

Luchsinger, J. A., Tang, M.-X., Shea, S., & Mayeux, R. (2004) · Neurology · doi:10.1212/01.wnl.0000140292.04932.87 · Cited by 683 · see citing works

Inflammation, Defective Insulin Signaling, and Mitochondrial Dysfunction as Common Molecular Denominators Connecting Type 2 Diabetes to Alzheimer Disease

Felice, F. G. D., & Ferreira, S. T. (2014) · Diabetes · doi:10.2337/db13-1954 · Cited by 647 · see citing works

Is Alzheimer’s disease a type 3 diabetes? A critical appraisal

Kandimalla, R., Thirumala, V., & Reddy, P. H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.08.018 · Cited by 621 · see citing works

Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI

den Heijer, T., Vermeer, S. E., van Dijk, E. J., Prins, N. D., Koudstaal, P. J., Albert Hofman, D., & Breteler, M. M. B. (2003) · Diabetologia · doi:10.1007/s00125-003-1235-0 · Cited by 512 · see citing works

Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes

Liu, Y. M., Liu, F., Grundke, I., Iqbal, K., & Gong, C. (2011) · The Journal of Pathology · doi:10.1002/path.2912 · Cited by 505 · see citing works

Insulin-degrading Enzyme as a Downstream Target of Insulin Receptor Signaling cascade: Implications for Alzheimer's Disease Intervention

Zhao, L., Teter, B., Morihara, T., Lim, G. P., Ambegaokar, S. S., Ubeda, O. J., Frautschy, S. A., & Cole, G. M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2860-04.2004 · Cited by 329 · see citing works

Type 2 diabetes mellitus and biomarkers of neurodegeneration

Moran, C., Beare, R. J., Phan, T. G., Bruce, D. G., Callisaya, M. L., & Srikanth, V. K. (2015) · Neurology · doi:10.1212/wnl.0000000000001982 · Cited by 298 · see citing works

Update of mortality attributable to diabetes for the IDF Diabetes Atlas: Estimates for the year 2013

IDF Diabetes Atlas Group (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.05.037 · Cited by 298 · see citing works

Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment

Li, X., Leng, S. X., & Song, D. (2015) · Clinical Interventions in Aging · doi:10.2147/cia.s74042 · Cited by 294 · see citing works

In Vivo Seeding and Cross-Seeding of Localized Amyloidosis

Oskarsson, M. E., Paulsson, J. F., Schultz, S. W., Ingelsson, M., Westermark, P., & Westermark, G. T. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.11.016 · Cited by 281 · see citing works

Defective insulin signaling pathway and increased GSK-3 activity in the brain of diabetic mice: parallels with Alzheimer’s disease and correction by insulin

Jolivalt, C. G., Lee, C. A., Beiswenger, K., Smith, J., Orlov, M., Torrance, M., & Masliah, E. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21787 · Cited by 281 · see citing works

HbA1c, diabetes and cognitive decline: the English Longitudinal Study of Ageing

Zheng, F., Yan, L., Yang, Z., Zhong, B., & Xie, W. (2018) · Diabetologia · doi:10.1007/s00125-017-4541-7 · Cited by 280 · see citing works

Global Prevalence of Type 2 Diabetes over the Next Ten Years (2018-2028)

Kaiser, A. B., Zhang, N. J., & van der Pluijm, W. (2018) · Diabetes · doi:10.2337/db18-202-lb · Cited by 274 · see citing works

Diabetes mellitus and cognitive impairments

Saedi, E., Gheini, M. R., Faiz, F., & Arami, M. A. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i17.412 · Cited by 269 · see citing works

Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis

Hoyer, S. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050067 · Cited by 265 · see citing works

Comparison of Alzheimer Aβ(1–40) and Aβ(1–42) amyloid fibrils reveals similar protofilament structures

Schmidt, M., Sachse, C., Richter, W., Chen, X., Fändrich, M., & Grigorieff, N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905007106 · Cited by 261 · see citing works

Untitled work

(2012) · PubMed · Cited by 248 · see citing works

The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non‐human primate model of Alzheimer's disease

Batista, A. F., Forny‐Germano, L., Clarke, J. R., Silva, N. M. L. E., Brito‐Moreira, J., Boehnke, S. E., Winterborn, A., Coe, B. C., Lablans, A., Vital, J. F. S., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5056 · Cited by 246 · see citing works

Molecular interaction between type 2 diabetes and Alzheimer’s disease through cross-seeding of protein misfolding

Moreno‐González, I., Edwards, G. A., Salvadores, N., Shahnawaz, M., Díaz‐Espinoza, R., & Soto, C. A. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.230 · Cited by 210 · see citing works

Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway

Zhu, L., Han, J., Yuan, R., Xue, L., & Pang, W. (2018) · Biological Research · doi:10.1186/s40659-018-0157-8 · Cited by 210 · see citing works

Kidney protection effects of dihydroquercetin on diabetic nephropathy through suppressing ROS and NLRP3 inflammasome

Ding, T., Wang, S., Zhang, X., Zai, W., Fan, J., Chen, W., Bian, Q., Luan, J., Shen, Y., Zhang, Y., et al. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.01.026 · Cited by 198 · see citing works

The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer’s Disease

Hansen, H. H., Fabricius, K., Barkholt, P., Niehoff, M. L., Morley, J. E., Jelsing, J., Pyke, C., Knudsen, L. B., Farr, S. A., & Vrang, N. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-143090 · Cited by 189 · see citing works

Type 2 Diabetes Is Negatively Associated With Alzheimer's Disease Neuropathology

Beeri, M. S., Silverman, J. M., Davis, K. L., Marin, D. B., Grossman, H. T., Schmeidler, J., Purohit, D. P., Perl, D. P., Davidson, M. H., Mohs, R. C., et al. (2005) · The Journals of Gerontology Series A · doi:10.1093/gerona/60.4.471 · Cited by 187 · see citing works

The effects of sitagliptin, a DPP-4 inhibitor, on cognitive functions in elderly diabetic patients with or without Alzheimer’s disease

Işık, A. T., Soysal, P., Yay, A., & Usarel, C. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.12.010 · Cited by 166 · see citing works

Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism

Liang, G., Song, L., Chen, Z., Qian, Y., Xie, J.-J., Zhao, L., Lin, Q., Zhu, G., Tan, Y., Li, X., et al. (2017) · Kidney International · doi:10.1016/j.kint.2017.05.013 · Cited by 161 · see citing works

Novel Roles for the Insulin-Regulated Glucose Transporter-4 in Hippocampally Dependent Memory

Pearson-Leary, J., & McNay, E. C. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1700-16.2016 · Cited by 158 · see citing works

Insulin-like growth factor receptor signaling regulates working memory, mitochondrial metabolism, and amyloid-β uptake in astrocytes

Logan, S., Pharaoh, G. A., Marlin, M. C., Masser, D. R., Matsuzaki, S., Wronowski, B., Yeganeh, A., Parks, E. E., Premkumar, P., Farley, J. A., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.01.013 · Cited by 156 · see citing works

Alzheimer’s disease and type 2 diabetes-related alterations in brain mitochondria, autophagy and synaptic markers

Carvalho, C., Santos, M. S., Oliveira, C. R., & Moreira, P. I. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.05.001 · Cited by 145 · see citing works

Rutin ameliorates diabetic neuropathy by lowering plasma glucose and decreasing oxidative stress via Nrf2 signaling pathway in rats

Tian, R., Yang, W., Xue, Q., Gao, L., Huo, J., Ren, D., & Chen, X. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.12.021 · Cited by 143 · see citing works

Neural correlates of liraglutide effects in persons at risk for Alzheimer’s disease

Watson, K. T., Wroolie, T., Tong, G., Foland‐Ross, L. C., Frangou, S., Singh, M. K., McIntyre, R. S., Roat-Shumway, S., Myoraku, A., Reiss, A. L., et al. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.08.006 · Cited by 134 · see citing works

Metformin attenuates diabetes-induced tau hyperphosphorylation in vitro and in vivo by enhancing autophagic clearance

Chen, J., Luo, C., Pu, D., Zhang, G., Zhao, Y., Sun, Y., Zhao, K., Liao, Z., Lv, A., Zhu, S., et al. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.09.008 · Cited by 131 · see citing works

Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3β pathway in an amyloid β protein induced alzheimer disease mouse model

Qi, L., Ke, L., Liu, X., Liao, L., Ke, S., Liu, X., Wang, Y., Lin, X., Zhou, Y., Wu, L., et al. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.04.052 · Cited by 128 · see citing works

DPP ‐4 Inhibitor Linagliptin Attenuates A β ‐induced Cytotoxicity through Activation of AMPK in Neuronal Cells

Kornelius, E., Lin, C., Chang, H., Li, H., Huang, W., Yang, Y., Lu, Y., Peng, C., & Huang, C. (2015) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12404 · Cited by 123 · see citing works

Advanced Glycation End Products Modulate Amyloidogenic APP Processing and Tau Phosphorylation: A Mechanistic Link between Glycation and the Development of Alzheimer’s Disease

Batkulwar, K., Godbole, R. K., Banarjee, R., Kassaar, O., Williams, R. J., & Kulkarni, M. J. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00410 · Cited by 121 · see citing works

Elevated glucose and oligomeric β-amyloid disrupt synapses via a common pathway of aberrant protein S-nitrosylation

Akhtar, M. W., Sanz‐Blasco, S., Dolatabadi, N., Parker, J., Chon, K., Lee, M. S., Soussou, W., McKercher, S. R., Ambasudhan, R., Nakamura, T., et al. (2016) · Nature Communications · doi:10.1038/ncomms10242 · Cited by 119 · see citing works

Amyloid‐β and islet amyloid pathologies link Alzheimer’s disease and type 2 diabetes in a transgenic model

Wijesekara, N., Ahrens, R., Sabale, M., Wu, L., Ha, K., Verdile, G., & Fraser, P. E. (2017) · The FASEB Journal · doi:10.1096/fj.201700431r · Cited by 117 · see citing works

Central activation of PPAR-gamma ameliorates diabetes induced cognitive dysfunction and improves BDNF expression

Kariharan, T., Nanayakkara, G., Parameshwaran, K., Bagasrawala, I., Ahuja, M., Abdel‐Rahman, E. A., Amin, A. T., Dhanasekaran, M., Suppiramaniam, V. D., & Amin, R. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.09.028 · Cited by 115 · see citing works

Neurotoxicity and Oxidative Damage of Beta Amyloid 1–42 versus Beta Amyloid 1–40 in the Mouse Cerebral Cortex

Klein, A., Kowall, N. W., & Ferrante, R. J. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07845.x · Cited by 114 · see citing works

Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer’s disease

Choi, B.-R., Cho, W.-H., Kim, J., Lee, H. J., Chung, C., Jeon, W. K., & Han, J.-S. (2014) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.147 · Cited by 111 · see citing works

Metformin Facilitates Amyloid-β Generation by β- and γ -Secretases via Autophagy Activation

Son, S. M., Shin, H., Byun, J., Kook, S. Y., Moon, M., Chang, Y. J., & Mook‐Jung, I. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151200 · Cited by 106 · see citing works

Increased susceptibility to metabolic dysregulation in a mouse model of Alzheimer's disease is associated with impaired hypothalamic insulin signaling and elevated BCAA levels

Ruiz, H. H., Chi, T., Shin, A. C., Lindtner, C., Hsieh, W., Ehrlich, M. E., Gandy, S., & Buettner, C. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.01.008 · Cited by 105 · see citing works

Age‐dependent impairment of glucose tolerance in the 3xTg‐AD mouse model of Alzheimer's disease

Vandal, M., White, P. J., Chevrier, G., Tremblay, C., St‐Amour, I., Planel, E., Marette, A., & Calon, F. (2015) · The FASEB Journal · doi:10.1096/fj.14-268482 · Cited by 103 · see citing works

Insulin-degrading enzyme in the Alzheimer's disease brain: prominent localization in neurons and senile plaques

Bernstein, H., Ansorge, S., Riederer, P. F., Reiser, M., Frölich, L., & Bogerts, B. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00135-4 · Cited by 101 · see citing works

Cerebral perfusion alterations in type 2 diabetes and its relation to insulin resistance and cognitive dysfunction

Cui, Y., Liang, X., Gu, H., et al. (2016) · Brain Imaging and Behavior · doi:10.1007/s11682-016-9583-9 · Cited by 99 · see citing works

Type 3 Diabetes: Cross Talk between Differentially Regulated Proteins of Type 2 Diabetes Mellitus and Alzheimer’s Disease

Mittal, K., Mani, R. J., & Katare, D. P. (2016) · Scientific Reports · doi:10.1038/srep25589 · Cited by 97 · see citing works

Cross-disease analysis of Alzheimer’s disease and type-2 Diabetes highlights the role of autophagy in the pathophysiology of two highly comorbid diseases

Caberlotto, L., Nguyen, T.-P., Lauria, M., Priami, C., Rimondini, R., Maioli, S., Cedazo-Mı́nguez, Á., Sita, G., Morroni, F., Corsi, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-39828-5 · Cited by 97 · see citing works

Exenatide reduces TNF-α expression and improves hippocampal neuron numbers and memory in streptozotocin treated rats

Solmaz, V., Çınar, B. P., Yiğittürk, G., Çavuşoğlu, T., Taşkıran, D., & Erbaş, O. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.09.024 · Cited by 96 · see citing works

Negative Regulation of TRPA1 by AMPK in Primary Sensory Neurons as a Potential Mechanism of Painful Diabetic Neuropathy

Wang, S., Kobayashi, K., Kogure, Y., et al. (2017) · Diabetes · doi:10.2337/db17-0503 · Cited by 95 · see citing works

Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation

Liu, Q., Zhang, F., Zhang, X., Cheng, R., Ma, J., Yi, J., & Li, J. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3256-x · Cited by 94 · see citing works

High β-Secretase Activity Elicits Neurodegeneration in Transgenic Mice Despite Reductions in Amyloid-β Levels

Rockenstein, E. M., Mante, M., Alford, M. F., Adame, A., Crews, L. A., Hashimoto, M., Esposito, L., Mucke, L., & Masliah, E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507016200 · Cited by 93 · see citing works

Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Reduces Alzheimer Disease-Associated Tau Hyperphosphorylation in the Hippocampus of Rats with Type 2 Diabetes

Xu, W., Yang, Y., Yuan, G., Zhu, W., Ma, D., & Hu, S. (2015) · Journal of Investigative Medicine · doi:10.1097/jim.0000000000000129 · Cited by 90 · see citing works

Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease

Velázquez, R., Tran, A., Ishimwe, E., Denner, L. A., Dave, N., Oddo, S., & Dineley, K. T. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.06.003 · Cited by 90 · see citing works

Agmatine ameliorates type 2 diabetes induced-Alzheimer's disease-like alterations in high-fat diet-fed mice via reactivation of blunted insulin signalling

Kang, S., Kim, C. H., Jung, H., Kim, E., Song, H., & Lee, J. E. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.10.029 · Cited by 89 · see citing works

Capsaicin reduces Alzheimer-associated tau changes in the hippocampus of type 2 diabetes rats

Xu, W., Liu, J., Ma, D., Yuan, G., Lü, Y., & Yang, Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172477 · Cited by 89 · see citing works

The Diabetic Retinopathy Barometer Study: Global perspectives on access to and experiences of diabetic retinopathy screening and treatment

Cavan, D. A., Makaroff, L., Fernandes, J. D. R., et al. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.03.023 · Cited by 89 · see citing works

Brain GLP-1/IGF-1 Signaling and Autophagy Mediate Exendin-4 Protection Against Apoptosis in Type 2 Diabetic Rats

Candeias, E., Sebastião, I., Cardoso, S., Carvalho, C., Santos, M. S., Oliveira, C. R., Moreira, P. I., & Duarte, A. I. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0622-3 · Cited by 88 · see citing works

Cognitive decline in type 2 diabetic db/db mice may be associated with brain region-specific metabolic disorders

Zheng, H. X., Zheng, Y., Zhao, L., Chen, M., Bai, G., Hu, Y., Hu, W., Yan, Z., & Gao, H. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.11.003 · Cited by 86 · see citing works

Huperzine A Ameliorates Cognitive Deficits in Streptozotocin-Induced Diabetic Rats

Mao, X., Cao, D., Li, X., Yin, J., Wang, Z., Zhang, Y., Mao, C., Zhou, H., & Liu, Z. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15057667 · Cited by 85 · see citing works

The BET/BRD inhibitor JQ1 improves brain plasticity in WT and APP mice

Benito, E., Ramachandran, B., Schroeder, H., Schmídt, G., Urbanke, H., Burkhardt, S., Capece, V., Dean, C., & Fischer, A. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.202 · Cited by 84 · see citing works

Management of Adults With Diabetes and Cognitive Problems

Hopkins, R. L., Shaver, K., & Weinstock, R. S. (2016) · Diabetes Spectrum · doi:10.2337/ds16-0035 · Cited by 83 · see citing works

Insulin Resistance is Associated with Increased Levels of Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease and Reduced Memory Function in At-Risk Healthy Middle-Aged Adults

Hoscheidt, S. M., Starks, E. J., Oh, J. M., Zetterberg, H., Blennow, K., Krause, R. A., Gleason, C. E., Puglielli, L., Atwood, C., Carlsson, C. M., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160110 · Cited by 82 · see citing works

Resveratrol Improves Cognitive Impairment by Regulating Apoptosis and Synaptic Plasticity in Streptozotocin-Induced Diabetic Rats

Tian, Z., Wang, J., Xu, M., Wang, Y., Zhang, M., & Zhou, Y. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000453216 · Cited by 82 · see citing works

Amylin–Aβ oligomers at atomic resolution using molecular dynamics simulations: a link between Type 2 diabetes and Alzheimer's disease

Baram, M., Atsmon‐Raz, Y., Ma, B., Nussinov, R., & Miller, Y. (2015) · Physical Chemistry Chemical Physics · doi:10.1039/c5cp03338a · Cited by 81 · see citing works

Insulin resistance-induced hyperglycemia decreased the activation of Akt/CREB in hippocampus neurons: Molecular evidence for mechanism of diabetes-induced cognitive dysfunction

Xiang, Q., Zhang, J., Li, C., Wang, Y., Zeng, M.-J., Cai, Z.-X., Tian, R.-B., Jia, W. P., & Li, X. (2015) · Neuropeptides · doi:10.1016/j.npep.2015.08.009 · Cited by 80 · see citing works

Type 2 diabetes mellitus might be a risk factor for mild cognitive impairment progressing to Alzheimer’s disease

Li, W., Wang, T., & Xiao, S. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s111298 · Cited by 80 · see citing works

The beta secretase BACE1 regulates the expression of insulin receptor in the liver

Meakin, P. J., Mezzapesa, A., Benabou, E., Haas, M. E., Bonardo, B., Grino, M., Brunel, J. M., Desbois‐Mouthon, C., Biddinger, S. B., Govers, R., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03755-2 · Cited by 80 · see citing works

Tannic acid as a natural antioxidant compound: Discovery of a potent metabolic enzyme inhibitor for a new therapeutic approach in diabetes and Alzheimer's disease

Türkan, F., Taslımı, P., & Saltan, F. Z. (2019) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22340 · Cited by 80 · see citing works

Ferulic acid attenuates diabetes-induced cognitive impairment in rats via regulation of PTP1B and insulin signaling pathway

Wang, H., Sun, X., Zhang, N., Ji, Z., Ma, Z., Fu, Q., Qu, R., & Ma, S. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2017.10.001 · Cited by 78 · see citing works

Andrographolide ameliorates diabetic retinopathy by inhibiting retinal angiogenesis and inflammation

Yu, Z., Lu, B., Sheng, Y., et al. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.01.014 · Cited by 76 · see citing works

Insula and Inferior Frontal Gyrus’ Activities Protect Memory Performance Against Alzheimer’s Disease Pathology in Old Age

Lin, F. V., Ren, P., Lo, R. Y., Chapman, B. P., Jacobs, A., Baran, T. M., Porsteinsson, A. P., Foxe, J. J., & Initiative, A. D. N. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160715 · Cited by 76 · see citing works

Metformin treatment ameliorates diabetes‐associated decline in hippocampal neurogenesis and memory via phosphorylation of insulin receptor substrate 1

Tanokashira, D., Kurata, E., Fukuokaya, W., Kawabe, K., Mana, K., Takeuchi, H., Nakazato, M., & Taguchi, A. (2018) · FEBS Open Bio · doi:10.1002/2211-5463.12436 · Cited by 76 · see citing works

High glucose upregulates BACE1-mediated Aβ production through ROS-dependent HIF-1α and LXRα/ABCA1-regulated lipid raft reorganization in SK-N-MC cells

Lee, H. J., Ryu, J. M., Jung, Y., Lee, S.-J., Kim, J. Y., Lee, S.-H., Hwang, I., Seong, J., & Han, H. (2016) · Scientific Reports · doi:10.1038/srep36746 · Cited by 75 · see citing works

The protective effect of formononetin on cognitive impairment in streptozotocin (STZ)-induced diabetic mice

Wang, J., Wang, L., Zhou, J., Qin, A., & Chen, Z. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.063 · Cited by 75 · see citing works

Gallic acid attenuates type I diabetic nephropathy in rats

Garud, M. S., & Kulkarni, Y. A. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.01.010 · Cited by 72 · see citing works

Berberine Ameliorates Diabetic Neuropathy: TRPV1 Modulation by PKC Pathway

Zan, Y., Kuai, C.-X., Qiu, Z., & Huang, F. (2017) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x17500926 · Cited by 71 · see citing works

DA5-CH, a novel GLP-1/GIP dual agonist, effectively ameliorates the cognitive impairments and pathology in the APP/PS1 mouse model of Alzheimer's disease

Cao, Y., Hölscher, C., Hu, M.-M., Wang, T., Zhao, F., Bai, Y., Zhang, J., Wu, M., & Qi, J. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.03.024 · Cited by 71 · see citing works

Anti-Diabetes Drug Pioglitazone Ameliorates Synaptic Defects in AD Transgenic Mice by Inhibiting Cyclin-Dependent Kinase5 Activity

Chen, J., Li, S., Sun, W.-S., & Li, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123864 · Cited by 70 · see citing works

Brain-Wide Insulin Resistance, Tau Phosphorylation Changes, and Hippocampal Neprilysin and Amyloid-β Alterations in a Monkey Model of Type 1 Diabetes

Morales‐Corraliza, J., Wong, H., Mazzella, M. J., Che, S., Lee, S. H., Petkova, E., Wagner, J. D., Hemby, S. E., Ginsberg, S. D., & Mathews, P. M. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.4640-14.2016 · Cited by 70 · see citing works

Lower risk of dementia with pioglitazone, compared with other second-line treatments, in metformin-based dual therapy: a population-based longitudinal study

Lu, C.-H., Yang, C., Li, C., Hsieh, C., & Ou, H. (2017) · Diabetologia · doi:10.1007/s00125-017-4499-5 · Cited by 70 · see citing works

Insulin is a potential antioxidant for diabetes-associated cognitive decline via regulating Nrf2 dependent antioxidant enzymes

Song, Y., Ding, W., Bei, Y., Xiao, Y. C., Tong, H.-D., Wang, L., & Ai, L.-Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.097 · Cited by 70 · see citing works

Cinacalcet-mediated activation of the CaMKKβ-LKB1-AMPK pathway attenuates diabetic nephropathy in db/db mice by modulation of apoptosis and autophagy

Lim, J. H., Kim, H. W., Kim, M. Y., Kim, T. W., Kim, E. N., Kim, Y., Chung, S., Kim, Y. S., Choi, B. S., Kim, Y., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0324-4 · Cited by 69 · see citing works

White matter hyperintensities in middle-aged adults with childhood-onset type 1 diabetes

Nunley, K. A., Ryan, C. M., Orchard, T. J., Aizenstein, H. J., Jennings, J. R., Ryan, J., Zgibor, J. C., Boudreau, R. M., Costacou, T., Maynard, J. D., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001582 · Cited by 68 · see citing works

Cyanidin-3-O-glucoside ameliorates diabetic nephropathy through regulation of glutathione pool

Qin, Y., Zhai, Q., Li, Y., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.137 · Cited by 68 · see citing works

Insulin deprivation induces PP2A inhibition and tau hyperphosphorylation in hTau mice, a model of Alzheimer’s disease-like tau pathology

Gratuze, M., Julien, J., Petry, F. R., Morin, F., & Planel, E. (2017) · Scientific Reports · doi:10.1038/srep46359 · Cited by 66 · see citing works

Liraglutide ameliorates cognitive decline by promoting autophagy via the AMP-activated protein kinase/mammalian target of rapamycin pathway in a streptozotocin-induced mouse model of diabetes

Kong, F., Wu, J., Sun, S., Ma, L., & Zhou, J. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.001 · Cited by 66 · see citing works

Increased dementia risk predominantly in diabetes mellitus rather than in hypertension or hyperlipidemia: a population-based cohort study

Fan, Y., Hsu, J., Tung, H., Chou, C.-C., & Bai, C. (2017) · Alzheimer s Research & Therapy · doi:10.1186/s13195-017-0236-z · Cited by 65 · see citing works

Insulin-signaling Pathway Regulates the Degradation of Amyloid β-protein via Astrocytes

Yamamoto, N., Ishikuro, R., Tanida, M., Suzuki, K., Ikeda‐Matsuo, Y., & Sobue, K. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.06.018 · Cited by 65 · see citing works

Progressive Neuronal Pathology and Synaptic Loss Induced by Prediabetes and Type 2 Diabetes in a Mouse Model of Alzheimer’s Disease

Ramos‐Rodríguez, J. J., Spires‐Jones, T. L., Pooler, A. M., Lechuga-Sancho, A. M., Bacskai, B. J., & Garcı́a-Alloza, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9921-3 · Cited by 64 · see citing works

Insulin differentially affects the distribution kinetics of amyloid beta 40 and 42 in plasma and brain

Swaminathan, S. K., Ahlschwede, K. M., Sarma, V., Curran, G. L., Omtri, R. S., Decklever, T. D., Lowe, V. J., Poduslo, J. F., & Kandimalla, K. K. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17709709 · Cited by 64 · see citing works

Type 2 Diabetes Mellitus and Impaired Renal Function Are Associated With Brain Alterations and Poststroke Cognitive Decline

Assayag, E. B., Eldor, R., Korczyn, A. D., Kliper, E., Shenhar‐Tsarfaty, S., Tene, O., Molad, J., Shapira, I., Berliner, S. A., Volfson, V., et al. (2017) · Stroke · doi:10.1161/strokeaha.117.017709 · Cited by 64 · see citing works

Triclosan-Evoked Neurotoxicity Involves NMDAR Subunits with the Specific Role of GluN2A in Caspase-3-Dependent Apoptosis

Szychowski, K. A., Wnuk, A., Rzemieniec, J., Kajta, M., Leszczyńska, T., & Wójtowicz, A. K. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1083-z · Cited by 64 · see citing works

Diabetes, Hemoglobin A1C, and Regional Alzheimer Disease and Infarct Pathology

Pruzin, J. J., Schneider, J. A., Capuano, A. W., Leurgans, S. E., Barnes, L. L., Ahima, R. S., Arnold, S. E., Bennett, D. A., & Arvanitakis, Z. (2016) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000172 · Cited by 63 · see citing works

Adiponectin controls the apoptosis and the expression of tight junction proteins in brain endothelial cells through AdipoR1 under beta amyloid toxicity

Song, J., Choi, S., Whitcomb, D. J., & Kim, B. C. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.491 · Cited by 61 · see citing works

The effects of safranal, a constitute of saffron, and metformin on spatial learning and memory impairments in type-1 diabetic rats: behavioral and hippocampal histopathological and biochemical evaluations

Delkhosh-Kasmaie, F., Farshid, A. A., Tamaddonfard, E., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.165 · Cited by 61 · see citing works

Vanillin Affects Amyloid Aggregation and Non-Enzymatic Glycation in Human Insulin

Iannuzzi, C., Borriello, M., Irace, G., Cammarota, M., Maro, A. D., & Sirangelo, I. (2017) · Scientific Reports · doi:10.1038/s41598-017-15503-5 · Cited by 59 · see citing works

Insulin sensitizers improve learning and attenuate tau hyperphosphorylation and neuroinflammation in 3xTg-AD mice

Yu, Y., Li, X., Blanchard, J., Li, Y., Iqbal, K., Liu, F., & Gong, C. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1294-z · Cited by 58 · see citing works

Zingerone (4-(4-hydroxy-3-methylphenyl)butan-2-one) ameliorates renal function via controlling oxidative burst and inflammation in experimental diabetic nephropathy

Rehman, M. U., Rashid, S. M., Rasool, S., et al. (2018) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2018.1448422 · Cited by 58 · see citing works

Accumulation of advanced glycation end products is associated with macrovascular events and glycaemic control with microvascular complications in Type 2 diabetes mellitus

Yozgatlı, T. K., Lefrandt, J. D., Noordzij, M. J., Oomen, P. H. N., Brouwer, T., Jäger, J., Cabezas, M. C., & Smit, A. J. (2018) · Diabetic Medicine · doi:10.1111/dme.13651 · Cited by 58 · see citing works

Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor Linagliptin

Lietzau, G., Davidsson, W., Östenson, C., Chiazza, F., Nathanson, D., Pintana, H., Skogsberg, J., Klein, T., Nyström, T., Darsalia, V., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0517-1 · Cited by 58 · see citing works

The Action of Polyphenols in Diabetes Mellitus and Alzheimer's Disease: A Common Agent for Overlapping Pathologies

Silveira, A. C. S., Dias, J. P., Santos, V. M., Oliveira, P. F., Alves, M. G., Rato, L., & Silva, B. M. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180803162059 · Cited by 58 · see citing works

Metformin Attenuates Aβ Pathology Mediated Through Levamisole Sensitive Nicotinic Acetylcholine Receptors in a C. elegans Model of Alzheimer’s Disease

Ahmad, W., & Ebert, P. R. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0085-y · Cited by 57 · see citing works

High Hemoglobin A1c and Diabetes Predict Memory Decline in the Health and Retirement Study

Marden, J. R., Mayeda, E. R., Tchetgen, E. J. T., Kawachi, I. I., & Glymour, M. M. (2017) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000182 · Cited by 57 · see citing works

Early-Stage Alzheimer’s Disease Is Associated with Simultaneous Systemic and Central Nervous System Dysregulation of Insulin-Linked Metabolic Pathways

de la Monte, S. M., Tong, M., Daiello, L. A., & Ott, B. R. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180906 · Cited by 57 · see citing works

Antidiabetic Drugs in Alzheimer’s Disease: Mechanisms of Action and Future Perspectives

Femminella, G. D., Bencivenga, L., Petraglia, L., Visaggi, L., Gioia, L., Grieco, F. V., de Lucia, C., Komici, K., Corbi, G., Edison, P., et al. (2017) · Journal of Diabetes Research · doi:10.1155/2017/7420796 · Cited by 56 · see citing works

Probucol prevents blood–brain barrier dysfunction and cognitive decline in mice maintained on pro-diabetic diet

Mamo, J. C. L., Lam, V., Brook, E., Mooranian, A., Al‐Salami, H., Fimognari, N., Nesbit, M., & Takechi, R. (2018) · Diabetes and Vascular Disease Research · doi:10.1177/1479164118795274 · Cited by 56 · see citing works

Autophagy-lysosome dysfunction is involved in Aβ deposition in STZ-induced diabetic rats

Ma, L., Lv, Y.-L., Huo, K., Liu, J., Shang, S., Fei, Y., Li, Y., Zhao, B., Wei, M., Deng, Y., et al. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.10.031 · Cited by 55 · see citing works

Reduced Gray Matter Volume in Patients with Type 2 Diabetes Mellitus

Liu, J., Liu, T., Wang, W., Ma, L., Ma, X., Shi, S., Gong, Q., & Wang, M. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00161 · Cited by 55 · see citing works

Carnosic acid improves diabetic nephropathy by activating Nrf2/ARE and inhibition of NF-κB pathway

Zhi-Sheng, X. I. E., Zhong, L., Wu, Y., Wan, X., Yang, H. Q., Xu, X., & Li, P. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.04.031 · Cited by 55 · see citing works

Plasma microRNA biomarker detection for mild cognitive impairment using differential correlation analysis

Kayano, M., Higaki, S., Satoh, J.-I., Matsumoto, K., Matsubara, E., Takikawa, O., & Niida, S. (2016) · Biomarker Research · doi:10.1186/s40364-016-0076-1 · Cited by 54 · see citing works

Tau ablation in mice leads to pancreatic β cell dysfunction and glucose intolerance

Wijesekara, N., Gonçalves, R. A., Ahrens, R., Felice, F. G. D., & Fraser, P. E. (2018) · The FASEB Journal · doi:10.1096/fj.201701352 · Cited by 54 · see citing works

Unraveling Alzheimer’s: Making Sense of the Relationship between Diabetes and Alzheimer’s Disease

Schilling, M. A. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150980 · Cited by 53 · see citing works

Chrysophanol Relieves Cognition Deficits and Neuronal Loss Through Inhibition of Inflammation in Diabetic Mice

Chu, X., Zhou, S., Sun, R., Wang, L., Xing, C., Liang, R.-Q., & Kong, Q. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2503-1 · Cited by 53 · see citing works

Etiology of type 2 diabetes and Alzheimer’s disease: Exploring the mitochondria

Silzer, T. K., & Phillips, N. R. (2018) · Mitochondrion · doi:10.1016/j.mito.2018.04.004 · Cited by 53 · see citing works

Distinct cognitive effects and underlying transcriptome changes upon inhibition of individual miRNAs in hippocampal neurons

Malmevik, J., Petri, R., Knauff, P., Brattås, P. L., Åkerblom, M., & Jakobsson, J. (2016) · Scientific Reports · doi:10.1038/srep19879 · Cited by 50 · see citing works

Humans with Type-2 Diabetes Show Abnormal Long-Term Potentiation-Like Cortical Plasticity Associated with Verbal Learning Deficits

Fried, P. J., Schilberg, L., Brem, A., Saxena, S., Wong, B., Cypess, A. M., Horton, E. S., & Pascual‐Leone, Á. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160505 · Cited by 50 · see citing works

Metabolic relationship between diabetes and Alzheimer's Disease affected by Cyclo(His-Pro) plus zinc treatment

Song, M. K., Bischoff, D. S., Song, A. M., Uyemura, K., & Yamaguchi, D. T. (2016) · BBA Clinical · doi:10.1016/j.bbacli.2016.09.003 · Cited by 48 · see citing works

Angiotensin-(1–7) administration attenuates Alzheimer’s disease-like neuropathology in rats with streptozotocin-induced diabetes via Mas receptor activation

Chen, J., Zhang, D., Sun, Y., Zhao, Y., Zhao, K., Pu, D., & Xiao, Q. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.01.027 · Cited by 48 · see citing works

Diabetes Mellitus Accelerates Aβ Pathology in Brain Accompanied by Enhanced GAβ Generation in Nonhuman Primates

Okabayashi, S., Shimozawa, N., Yasutomi, Y., Yanagisawa, K., & Kimura, N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117362 · Cited by 47 · see citing works

Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer’s Disease

Geijselaers, S. L. C., Aalten, P., Ramakers, I. H. G. B., Deyn, P. P. D., Heijboer, A. C., Koek, H. L., Olde-Rikkert, M. G. M., Papma, J. M., Reesink, F. E., Smits, L. L., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170522 · Cited by 47 · see citing works

Tau hyperphosphorylation in the brain of ob/ob mice is due to hypothermia: Importance of thermoregulation in linking diabetes and Alzheimer's disease

Gratuze, M., Khoury, N. B. E., Turgeon, A., Julien, C., Marcouiller, F., Morin, F., Whittington, R. A., Marette, A., Calon, F., & Planel, E. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.10.004 · Cited by 45 · see citing works

Vildagliptin, a DPP4 inhibitor, alleviates diabetes‑associated cognitive deficits by decreasing the levels of apoptosis‑related proteins in the rat hippocampus

Zhang, D., Shi, N., Fang, H., Ma, L., Wu, W., Zhang, Y., Tian, J., Tian, L., Kang, K., & Chen, S. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6016 · Cited by 43 · see citing works

Synergistic Exacerbation of Mitochondrial and Synaptic Dysfunction and Resultant Learning and Memory Deficit in a Mouse Model of Diabetic Alzheimer's Disease

Wang, Y., Wu, L., Li, J., Du, F., Zhong, C., Chen, J. X., & Yan, S. S. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140972 · Cited by 42 · see citing works

Hypothermia mediates age-dependent increase of tau phosphorylation in db/db mice

Khoury, N. B. E., Gratuze, M., Petry, F. R., Papon, M.-A., Julien, C., Marcouiller, F., Morin, F., Nicholls, S. B., Calon, F., Hébert, S. S., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.01.005 · Cited by 42 · see citing works

The Associations among Insulin Resistance, Hyperglycemia, Physical Performance, Diabetes Mellitus, and Cognitive Function in Relatively Healthy Older Adults with Subtle Cognitive Dysfunction

Umegaki, H., Makino, T., Uemura, K., Shimada, H., Hayashi, T., Cheng, X. W., & Kuzuya, M. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00072 · Cited by 42 · see citing works

Anti-diabetic vanadyl complexes reduced Alzheimer’s disease pathology independent of amyloid plaque deposition

Dong, Y., Stewart, T., Zhang, Y., Shi, M. Y., Tan, C., Li, X., Yuan, L., Mehrotra, A., Zhang, J., & Yang, X. (2018) · Science China Life Sciences · doi:10.1007/s11427-018-9350-1 · Cited by 42 · see citing works

Ghrelin-Attenuated Cognitive Dysfunction in Streptozotocin-induced Diabetic Rats

Ma, L., Zhang, D., Tang, Y. C., Lu, Y., Zhang⋆, Y., Gao, Y., Li, X., Zhao, K., Chai, L., & Xiao, Q. (2011) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31820ce536 · Cited by 40 · see citing works

Intranasal insulin treatment restores cognitive deficits and insulin signaling impairment induced by repeated methamphetamine exposure

Beirami, E., Oryan, S., Tamijani, S. M. S., Ahmadiani, A., & Dargahi, L. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26398 · Cited by 40 · see citing works

Blood glucose levels and cortical thinning in cognitively normal, middle-aged adults

Wennberg, A. M. V., Spira, A. P., Pettigrew, C. A., Soldan, A., Zipunnikov, V. M., Rebok, G. W., Roses, A. D., Lutz, M. W., Miller, M. M., Thambisetty, M., et al. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.04.017 · Cited by 39 · see citing works

White Matter Hyperintensity in Elderly Patients with Diabetes Mellitus Is Associated with Cognitive Impairment, Functional Disability, and a High Glycoalbumin/Glycohemoglobin Ratio

Tamura, Y., Kimbara, Y., Yamaoka, T., et al. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00220 · Cited by 39 · see citing works

Renoprotective effect of nifuroxazide in diabetes-induced nephropathy: impact on NFκB, oxidative stress, and apoptosis

Elsherbiny, N. M., Zaitone, S. A., Mohammad, H. M. F., et al. (2018) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2018.1459995 · Cited by 39 · see citing works

Erythropoietin ameliorates diabetes-associated cognitive dysfunction in vitro and in vivo

Wang, M., Yan, W., Liu, Y., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-03137-6 · Cited by 38 · see citing works

The BACE1 product sAPPβ induces ER stress and inflammation and impairs insulin signaling

Botteri, G., Salvadó, L., Gumà, A., Hamilton, D. L., Meakin, P. J., Montagut, G., Ashford, M. L. J., Ceperuelo‐Mallafré, V., Fernández‐Veledo, S., Vendrell, J. J., et al. (2018) · Metabolism · doi:10.1016/j.metabol.2018.03.005 · Cited by 38 · see citing works

Effects of ageing and experimental diabetes on insulin-degrading enzyme expression in male rat tissues

Kochkina, E. G., Plesneva, S. A., Vasilev, D. S., Zhuravin, I. A., Turner, A. J., & Nalivaeva, N. N. (2015) · Biogerontology · doi:10.1007/s10522-015-9569-9 · Cited by 37 · see citing works

Gavage of D-Ribose induces Aβ-like deposits, Tau hyperphosphorylation as well as memory loss and anxiety-like behavior in mice

Wu, B., Yan, W., Wang, Y., Su, T., Zhou, L., Liu, Y., & He, R. (2015) · Oncotarget · doi:10.18632/oncotarget.6021 · Cited by 36 · see citing works

Dementia-like pathology in type-2 diabetes: A novel microRNA mechanism

Kalani, A., Chaturvedi, P., Maldonado, C. J., Bauer, P. M., Joshua, I. G., Tyagi, S. C., & Tyagi, N. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.02.005 · Cited by 36 · see citing works

Combining SGLT2 Inhibition With a Thiazolidinedione Additively Attenuate the Very Early Phase of Diabetic Nephropathy Progression in Type 2 Diabetes Mellitus

Han, E., Shin, E., Kim, G., Lee, J.-Y., Lee, Y., Lee, B., Kang, E. S., & Soo, B. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00412 · Cited by 36 · see citing works

Chronic diabetic states worsen Alzheimer neuropathology and cognitive deficits accompanying disruption of calcium signaling in leptin-deficient APP/PS1 mice

Zhang, S., Chai, R., Yang, Y., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17116 · Cited by 35 · see citing works

Diabetes mellitus and Alzheimer's disease: glycation as a biochemical link

Smith, M. A. (1996) · Diabetologia · doi:10.1007/bf00403972 · Cited by 34 · see citing works

Naringin ameliorates cognitive deficits in streptozotocin-induced diabetic rats.

Xianchu, L., Ming, L., Mo, Y., et al. (2016) · PubMed · Cited by 33 · see citing works

Amylin Signaling in Diabetes and Alzheimer's Disease: Therapy or Pathology?

Grizzanti, J., Corrigan, R. R., Servizi, S., & Casadesús, G. (2019) · Journal of Neurology and Neuromedicine · doi:10.29245/2572.942x/2019/1.1212 · Cited by 33 · see citing works

Detection of the receptor for advanced glycation endproducts in neuronally-derived exosomes in plasma

Patterson, S. A., Deep, G., & Brinkley, T. E. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.04.181 · Cited by 32 · see citing works

Exendin-4 reduces tau hyperphosphorylation in type 2 diabetic rats via increasing brain insulin level

Yang, Y., Ma, D., Xu, W., Chen, F., Du, T., Yue, W., Shao, S., & Yuan, G. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.10.005 · Cited by 31 · see citing works

Rapamycin inhibits activation of AMPK-mTOR signaling pathway-induced Alzheimer’s disease lesion in hippocampus of rats with type 2 diabetes mellitus

Sun, Q., Wei, L., Zhang, M., Li, T., Yang, C., Deng, S., & Zeng, Q.-C. (2018) · International Journal of Neuroscience · doi:10.1080/00207454.2018.1491571 · Cited by 31 · see citing works

cAMP/PKA signaling pathway contributes to neuronal apoptosis via regulating IDE expression in a mixed model of type 2 diabetes and Alzheimer's disease

Li, H., Yang, S. R., Wu, J. H., Ji, L., Zhu, L., Cao, L., Huang, J., Jiang, Q., Jiang, W., Liu, M., et al. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26321 · Cited by 30 · see citing works

Red peppers with moderate and severe pungency prevent the memory deficit and hepatic insulin resistance in diabetic rats with Alzheimer’s disease

Yang, H. J., Kwon, D. Y., Kim, M. J., Kang, S., Moon, N. R., Daily, J. W., & Park, S. (2015) · Nutrition & Metabolism · doi:10.1186/s12986-015-0005-6 · Cited by 29 · see citing works

Identification of diabetes-related dementia: Longitudinal perfusion SPECT and amyloid PET studies

Fukasawa, R., Hanyu, H., Shimizu, S., Kanetaka, H., Sakurai, H., & Ishii, K. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.12.023 · Cited by 28 · see citing works

Disrupted subject‐specific gray matter network properties and cognitive dysfunction in type 1 diabetes patients with and without proliferative retinopathy

van Duinkerken, E., IJzerman, R. G., Klein, M., Moll, A. C., Snoek, F. J., Scheltens, P., Pouwels, P. J. W., Barkhof, F., Diamant, M., & Tijms, B. M. (2015) · Human Brain Mapping · doi:10.1002/hbm.23096 · Cited by 28 · see citing works

Insulin deficiency results in reversible protein kinase A activation and tau phosphorylation

van der Harg, J. M., Eggels, L., Bangel, F. N., Ruigrok, S. R., Zwart, R., Hoozemans, J. J. M., la Fleur, S. E., & Scheper, W. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.04.005 · Cited by 28 · see citing works

The BET/BRD inhibitor JQ1 attenuates diabetes-induced cognitive impairment in rats by targeting Nox4-Nrf2 redox imbalance

Liang, E., Ma, M., Wang, L., Liu, X., Xu, J., Zhang, M., Yang, R., & Zhao, Y. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.11.020 · Cited by 28 · see citing works

Korean Thistle (Cirsium japonicum var. maackii (Maxim.) Matsum.): A Potential Dietary Supplement against Diabetes and Alzheimer’s Disease

Wagle, A., Seong, S. H., Shrestha, S., Jung, H. A., & Choi, J. S. (2019) · Molecules · doi:10.3390/molecules24030649 · Cited by 28 · see citing works

Inflammatory Macrophages Promotes Development of Diabetic Encephalopathy

Wang, B., Miao, Y., Zhao, Z., et al. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430285 · Cited by 27 · see citing works

Thyroid hormone improves insulin signaling and reduces the activation of neurodegenerative pathway in the hippocampus of diabetic adult male rats

Prieto-Almeida, F., Panveloski-Costa, A. C., Crunfli, F., Teixeira, S. D. S., Nunes, M. T., & Torrão, A. D. S. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.11.013 · Cited by 27 · see citing works

The Research on the Relationship of RAGE, LRP-1, and Aβ Accumulation in the Hippocampus, Prefrontal Lobe, and Amygdala of STZ-Induced Diabetic Rats

Ma, L., Fei, Y., Wang, X., Wu, S., Du, J., Zhu, M., Jin, L., Li, M., Liu, X., Zhai, J., et al. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-0892-2 · Cited by 26 · see citing works

The role of melatonin in the onset and progression of type 3 diabetes

Song, J., Whitcomb, D. J., & Kim, B. C. (2017) · Molecular Brain · doi:10.1186/s13041-017-0315-x · Cited by 26 · see citing works

DPP4 Inhibitors Can Be a Drug of Choice for Type 3 Diabetes: A Mini Review

Chalichem, N. S. S., Gonugunta, C., Krishnamurthy, P. T., & Basavan, D. (2017) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317517722005 · Cited by 26 · see citing works

A curcumin derivative J147 ameliorates diabetic peripheral neuropathy in streptozotocin (STZ)-induced DPN rat models through negative regulation AMPK on TRPA1

Lv, J., Cao, L., Zhang, R., Bai, F., & Wei, P. (2018) · Acta Cirúrgica Brasileira · doi:10.1590/s0102-865020180060000008 · Cited by 26 · see citing works

Duration of Type 2 Diabetes and Very Low Density Lipoprotein Levels Are Associated with Cognitive Dysfunction in Metabolic Syndrome

Yogi-Morren, D., Galioto, R., Strandjord, S. E., Kennedy, L., Manroa, P., Kirwan, J. P., Kashyap, S. R., & Gunstad, J. (2014) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2014/656341 · Cited by 25 · see citing works

Unexpected partial correction of metabolic and behavioral phenotypes of Alzheimer’s APP/PSEN1 mice by gene targeting of diabetes/Alzheimer’s-related Sorcs1

Knight, E. M., Ruiz, H. H., Kim, S. H., Harte, J. C., Hsieh, W., Glabe, C. G., Klein, W. L., Attie, A., Buettner, C., Ehrlich, M. E., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0282-y · Cited by 25 · see citing works

Experimentally induced diabetes worsens neuropathology, but not learning and memory, in middle aged 3xTg mice

Hayashi-Park, E., Ozment, B. N., Griffith, C. M., Zhang, H., Patrylo, P. R., & Rose, G. M. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.05.020 · Cited by 25 · see citing works

Alzheimer's genetic risk intensifies neurocognitive slowing associated with diabetes in nondemented older adults

McFall, G. P., Wiebe, S. A., Vergote, D., Anstey, K. J., & Dixon, R. A. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.08.002 · Cited by 23 · see citing works

Insulin resistance and cognitive test performance in elderly adults: National health and nutrition examination survey (NHANES)

Sherzai, A. Z., Shaheen, M. A., Yu, J. J., Talbot, K., & Sherzai, D. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.11.031 · Cited by 23 · see citing works

Altered Insulin/Insulin-Like Growth Factor Signaling in a Comorbid Rat model of Ischemia and β-Amyloid Toxicity

Amtul, Z., Hill, D. J., Arany, E. J., & Cechetto, D. F. (2018) · Scientific Reports · doi:10.1038/s41598-018-22985-4 · Cited by 23 · see citing works

Are Tanycytes the Missing Link Between Type 2 Diabetes and Alzheimer’s Disease?

Raikwar, S. P., Bhagavan, S., Ramaswamy, S. B., Thangavel, R., Dubova, I., Selvakumar, G. P., Ahmed, M. E., Kempuraj, D., Zaheer, S. A., Iyer, S. S., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1123-8 · Cited by 22 · see citing works

Plasma Amyloid-β Peptides in Type 2 Diabetes: A Matched Case-Control Study

Peters, K. E., Davis, W. A., Taddei, K., Martins, R. N., Masters, C. L., Davis, T. M. E., & Bruce, D. G. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161050 · Cited by 21 · see citing works

Effect of pioglitazone and simvastatin in lipopolysaccharide-induced amyloidogenesis and cognitive impairment in mice: possible role of glutamatergic pathway and oxidative stress

Ekladious, S. T., & Sayed, N. S. E. (2018) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000407 · Cited by 21 · see citing works

Modelling incremental benefits on complications rates when targeting lower HbA 1c levels in people with Type 2 diabetes and cardiovascular disease

Mostafa, S. A., Coleman, R. L., Agbaje, O. F., Gray, A. M., Holman, R. R., & Bethel, M. A. (2017) · Diabetic Medicine · doi:10.1111/dme.13533 · Cited by 20 · see citing works

Insulin treatment partially prevents cognitive and hippocampal alterations as well as glucocorticoid dysregulation in early-onset insulin-deficient diabetic rats

Marissal‐Arvy, N., Campas, M.-N., Sémont, A., Ducroix-Crepy, C., Beauvieux, M.-C., Brossaud, J., Corcuff, J., Helbling, J., Vancassel, S., Bouzier‐Sore, A., et al. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.04.016 · Cited by 20 · see citing works

Low glucagon-like peptide-1 (GLP-1) concentration in serum is indicative of mild cognitive impairment in type 2 diabetes patients

Wu, P., Zhao, Y., Zhuang, X., Sun, A., Zhang, Y., & Ni, Y. (2018) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2018.08.012 · Cited by 20 · see citing works

The Natural Rotenoid Deguelin Ameliorates Diabetic Neuropathy by Decreasing Oxidative Stress and Plasma Glucose Levels in Rats via the Nrf2 Signalling Pathway

Chen, J., Liu, W., Yi, H., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000491983 · Cited by 20 · see citing works

ε3/4 genotype of the apolipoprotein E is associated with higher risk of Alzheimer's disease in patients with type 2 diabetes mellitus

Tang, Y., Li, Y., Zhang, M., Chen, Y., & Sun, Q. (2019) · Gene · doi:10.1016/j.gene.2019.03.024 · Cited by 18 · see citing works

Expression analysis of inflammatory response-associated genes in coronary artery disease

Ebadi, N., Ghafouri‐Fard, S., Taheri, M. N., Arsang‐Jang, S., & Omrani, M. D. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2019.1708953 · Cited by 17 · see citing works

Evaluation of a combination digital retinal camera with spectral-domain optical coherence tomography (SD-OCT) that might be used for the screening of diabetic retinopathy with telemedicine: A pilot study

Sanborn, G. E., & Wroblewski, J. J. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.08.010 · Cited by 16 · see citing works

Interleukin-1β: A common cause of alzheimer's disease and diabetes mellitus

Holden, R. J., & Mooney, P. A. (1995) · Medical Hypotheses · doi:10.1016/0306-9877(95)90240-6 · Cited by 15 · see citing works

The Improving Effect of HL271, a Chemical Derivative of Metformin, a Popular Drug for Type II Diabetes Mellitus, on Aging-induced Cognitive Decline

Bang, E., Lee, B., Park, J.-O., Jang, Y., Kim, A., Kim, S., & Shin, H. (2018) · Experimental Neurobiology · doi:10.5607/en.2018.27.1.45 · Cited by 15 · see citing works

Atrophy in Distributed Networks Predicts Cognition in Alzheimer’s Disease and Type 2 Diabetes

Buss, S. S., Padmanabhan, J. L., Saxena, S., Pascual‐Leone, Á., & Fried, P. J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180570 · Cited by 15 · see citing works

Gene therapy with the angiogenic neuropeptide secretoneurin ameliorates experimental diabetic neuropathy

Theurl, M., Lener, D., Albrecht-Schgoer, K., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201701391r · Cited by 13 · see citing works

Long intergenic noncoding RNA p21 suppresses the apoptosis of hippocampus neurons in streptozotocin‐diabetic mice by sponging microRNA‐221 through upregulation of FOS

Sun, Q., Zeng, Q.-C., Chen, Y., Zhang, M., Wei, L., & Chen, P. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28714 · Cited by 13 · see citing works

Assessment of the therapeutic potential of hesperidin and proteomic resolution of diabetes-mediated neuronal fluctuations expediting Alzheimer’s disease

Khowal, S., Mustufa, M. M. A., Chaudhary, N. K., Naqvi, S. H., Parvez, S., Jain, S. K., & Wajid, S. (2015) · RSC Advances · doi:10.1039/c5ra01977j · Cited by 12 · see citing works

Secreted amyloid precursor protein alpha activates neuronal insulin receptors and prevents diabetes-induced encephalopathy

Aulston, B. D., Schapansky, J., Huang, Y.-W., Odero, G. L., & Glazner, G. W. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.01.013 · Cited by 12 · see citing works

Matrix metalloproteinase 14 modulates diabetes and Alzheimer’s disease cross-talk: a meta-analysis

Cheng, J., Liu, H.-P., Lee, C.-C., Chen, M.-Y., Lin, W., & Tsai, F. (2017) · Neurological Sciences · doi:10.1007/s10072-017-3166-4 · Cited by 11 · see citing works

Spontaneous recovery of fear differs among early – late adolescent and adult male mice

Ishii, D., Matsuzawa, D., Matsuda, S., Tomizawa-Shinohara, H., Sutoh, C., & Shimizu, E. (2018) · International Journal of Neuroscience · doi:10.1080/00207454.2018.1501049 · Cited by 11 · see citing works

Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates kidney injury in murine models of obesity and diabetes mellitus

Patel, V. J., Joharapurkar, A. A., Kshirsagar, S. G., Sutariya, B., Patel, M. S., Patel, H. M., Pandey, D., Bahekar, R. H., & Jain, M. R. (2018) · World Journal of Diabetes · doi:10.4239/wjd.v9.i6.80 · Cited by 11 · see citing works

Proteomic Analysis of Hippocampus and Cortex in Streptozotocin-Induced Diabetic Model Mice Showing Dementia

Matsuura, K., Otani, M., Takano, M., Kadoyama, K., & Matsuyama, S. (2018) · Journal of Diabetes Research · doi:10.1155/2018/8953015 · Cited by 10 · see citing works

Proteomic research of high-glucose-activated endothelial microparticles and related proteins to Alzheimer’s disease

Zu, L., Niu, C., Li, J., et al. (2015) · Diabetes and Vascular Disease Research · doi:10.1177/1479164115597865 · Cited by 9 · see citing works

NON‐INSULIN‐DEPENDENT DIABETES MELLITUS AND ALZHEIMER'S DISEASE

Landi, F., Bernabei, R., & Gambassi, G. (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb03108.x · Cited by 8 · see citing works

Dietary polyphenols: Regulate the advanced glycation end products-RAGE axis and the microbiota-gut-brain axis to prevent neurodegenerative diseases

Li, Y., Peng, Y., Shen, Y., Zhang, Y., Liu, L., & Yang, X. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2076064 · Cited by 156 · see citing works

Phytotherapy: A promising approach for the treatment of Alzheimer's disease

John, O. O., Amarachi, I. S., Chinazom, A. P., Adaeze, E., Kale, M. B., Umare, M. D., & Upaganlawar, A. B. (2022) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2021.100030 · Cited by 69 · see citing works

Estrogenic plants: to prevent neurodegeneration and memory loss and other symptoms in women after menopause

Echeverria, V., Echeverria, F., Barreto, G. E., Echeverría, J., & Mendoza, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.644103 · Cited by 52 · see citing works

Skin Aging, Glycation and Glycation Inhibitors

Farris, P. K. (2013) · doi:10.1002/9781118384824.ch17 · Cited by 2 · see citing works

Differential glycation of rat α-, β- and γ-crystallins

Swamy, M. S., & Abraham, E. C. (1991) · Experimental Eye Research · doi:10.1016/0014-4835(91)90040-l · Cited by 30 · see citing works

Glycation of Human Lens Crystallins: Effect of Age and Aspirin Treatment

Cherian, M., & Abraham, E. C. (2009) · Ophthalmic Research · doi:10.1159/000267336 · Cited by 13 · see citing works

[Biochemical properties and clinical significance of protein glycation products].

Staniszewska, M. M., & Gamian, A. (2003) · PubMed · Cited by 2 · see citing works

Tau hyperphosphorylation induces apoptotic escape and triggers neurodegeneration in Alzheimer’s disease

Wang, J., Wang, Z.-H., & Tian, Q. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1415-y · Cited by 74 · see citing works